What is Driving the Growth of the Osteoarthritis Therapeutics Market?

The osteoarthritis therapeutics market has witnessed robust growth in recent years, largely due to the increasing prevalence of osteoarthritis (OA), an age-related degenerative joint disease that affects millions globally. The market was valued at USD 9.13 billion in 2024 and is forecasted to grow at a CAGR of 8.70% between 2025 and 2034, reaching USD 21.03 billion by 2034.

Osteoarthritis is one of the most common musculoskeletal conditions, significantly impacting quality of life and mobility. The growing elderly population, rise in obesity, sedentary lifestyles, and increasing awareness of early diagnosis and treatment options are driving demand for innovative therapeutics. Additionally, pharmaceutical advancements, such as biologics and disease-modifying drugs, are expected to create new growth opportunities.

Market Segmentation of the Osteoarthritis Therapeutics Market

The market is segmented by type, drug class, dosage form, route of administration, end user, distribution channel, and region.

1. Market Breakup by Type

• Hip Osteoarthritis – Increasing cases due to aging and obesity are fueling treatment demand.

• Spinal Osteoarthritis – Rising prevalence of back pain and spinal degeneration contributes to growth.

• Knee Osteoarthritis – The largest segment, driven by high incidence rates and physical inactivity.

• Hand Osteoarthritis – Gaining attention with a growing elderly population.

• Others – Includes shoulder and ankle osteoarthritis.

Knee osteoarthritis dominates the market, given its widespread prevalence and impact on mobility.

2. Market Breakup by Drug Class

• Nonsteroidal Anti-inflammatory Drugs (NSAIDs) – Widely prescribed for pain management.

• Other Analgesics – Including acetaminophen, used in mild cases.

• Corticosteroids – Administered via injections for temporary relief.

• Hyaluronic Acid Injections – Popular in advanced OA stages for lubrication therapy.

• Others – Including biologics and disease-modifying therapies.

NSAIDs and corticosteroids remain the most commonly used treatments, but biologics are gaining traction as potential long-term solutions.

3. Market Breakup by Dosage Form

• Tablets and Capsules – The most convenient and widely used.

• Injections – Preferred for advanced stages, particularly corticosteroids and hyaluronic acid.

• Creams and Gels – Non-invasive pain relief for localized treatment.

• Others – Including patches and sprays.

Oral formulations dominate, but injectables are expected to grow faster due to efficacy in late-stage OA management.

4. Market Breakup by Route of Administration

• Oral – Most prevalent due to patient preference.

• Parenteral – Common in hospital and specialty settings.

• Topical – Favored for mild OA and fewer systemic side effects.

5. Market Breakup by End User

• Hospitals – Major centers for advanced OA treatment.

• Specialty Clinics – Growing due to rising orthopedic and rheumatology consultations.

• Homecare Settings – Increasing with self-management and OTC drugs.

• Others

Hospitals and specialty clinics together account for the largest share, though homecare is growing with digital pharmacies.

6. Market Breakup by Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies – Fastest-growing, driven by convenience and digital adoption.

• Others

7. Market Breakup by Region

• United States – Largest market due to high prevalence, advanced healthcare, and R&D.

• EU-4 and the United Kingdom – Significant due to aging population.

  • Germany

  • France

  • Italy

  • Spain

  • United Kingdom

• Japan – Growing rapidly with its super-aged population.

• India – Emerging market with increasing healthcare access.

Key Growth Drivers of the Osteoarthritis Therapeutics Market

• Rising Prevalence of Osteoarthritis – OA affects over 500 million people globally, with North America, Europe, and Asia being the most impacted.

• Aging Population – Older adults are more prone to joint degeneration, fueling demand for therapies.

• Pharmaceutical Innovations – Development of biologics and disease-modifying osteoarthritis drugs (DMOADs).

• Increasing Obesity Rates – Obesity is a major risk factor, increasing knee and hip osteoarthritis cases.

• Digital Health and Telemedicine – Enabling better OA management and prescription access.

Competitive Landscape

The osteoarthritis therapeutics market is highly competitive, with global pharma companies actively expanding portfolios. Key players include:

• Sanofi

• Bayer AG

• Haleon plc

• Seikagaku Corporation

• Bristol Myers Squibb

• Ono Pharmaceutical

• Novartis AG

• Pfizer Inc.

• Assertio Holdings

• Pacira Biosciences Inc.

• Anika Therapeutics Inc.

• Bioventus LLC

These companies are investing heavily in clinical trials, biologics, and minimally invasive treatments. Collaborations with biotech firms and universities are accelerating the development of next-gen therapies.

Future Outlook of the Osteoarthritis Therapeutics Market

The market outlook remains positive, with continuous investment in drug innovation and shift toward precision medicine. Biologics and regenerative therapies (such as stem cell and gene therapy) are expected to reshape treatment approaches by 2034.

Furthermore, digital health tools like wearable devices for pain monitoring and AI-powered diagnostic solutions will support early intervention and personalized treatment strategies.

View More Reports

Nanopore Sequencing Market

Osteoporosis Drug Pipeline Analysis Report

India Disposable Medical Gloves Market

CDMO Market Size

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com